Enroll Your Patients in a Support Program Providing Access to Financial Resources Based on Their Prescribed Treatment
Each year, the publishers of Oncology Practice Management update this comprehensive guide to sponsored patient support programs to help you guide your patients to tools and resources that provide more affordable access to their prescribed medications.
The services provided by each company will vary, but most pharmaceutical companies provide patient education about the disease and the prescribed treatment and offer financial assistance for those patients who meet eligibility requirements. Support programs sponsored by pharmaceutical manufacturers may include services such as:
- Copay assistance programs for patients with commercial insurance
- Patient assistance programs for underinsured or uninsured patients
- Medication bridge/temporary access programs
- Dose exchange programs
These services can be of critical help to patients, alleviating some of the anxiety and financial pressures that patients experience when dealing with a cancer diagnosis. In addition to patient support, there are also services to help you and your office staff, such as benefit verification, insurance coverage determination, prior authorizations, and claims/appeals support.
This Guide organizes patient support programs by company name and lists the services each company offers for each drug. A list by drug name is included in the index.
We encourage all oncology healthcare providers to use the Guide and share this information with patients. We hope the Guide proves to be a useful tool to you in your practice.
EDITOR’S NOTE: The company profiles in this Guide are based on information posted online by the respective pharmaceutical companies as of November 6, 2025. Every effort has been made to verify the information up to that time. Any updates, including new drugs approved after that time, will not appear in this publication, but they will be added to the Guide on the Oncology Practice Management website. The Publisher and the Editors are not responsible for any inaccuracies stemming from changes, new drug approvals, or company updates that became available later. Readers are advised to review the websites of each drug company for any updates and revisions.